Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination

Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination

Viruses expressing tumour antigens can prime and boost anti-tumour immunity but the efficiency of this approach depends on the capacity of the virus to infect the host. Here, the authors show that vaccination with oncolytic viruses co-administered with tumour antigenic peptides is as efficient as an...

Full description

Saved in:
Bibliographic Details
Main Authors: D. G. Roy, K. Geoffroy, M. Marguerie, S. T. Khan, N. T. Martin, J. Kmiecik, D. Bobbala, A. S. Aitken, C. T. de Souza, K. B. Stephenson, B. D. Lichty, R. C. Auer, D. F. Stojdl, J. C. Bell, M.-C. Bourgeois-Daigneault
Format: article
Language:EN
Published: Nature Portfolio 2021
Subjects:
Science
Q
Online Access:https://doaj.org/article/0087d0d0e932497c868d4c3d99452a6d
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/0087d0d0e932497c868d4c3d99452a6d

Similar Items